Table_1_The moderating role of the late positive potential in the link between attachment anxiety and emotion regulation difficulties.DOCX by Miguel Ramos-Henderson (12530649)

“…</p>Results<p>Interestingly, we found that greater LPP amplitudes during reappraisal implementation intensified the association between attachment anxiety and emotional regulation difficulties. …”

Data_Sheet_1_Depression and health literacy among adolescents and adults in Germany: findings from two representative samples.pdf by Lars König (3440474)

“…Levels of health literacy (HLS-EU-Q16 questionnaire), depressive symptom severity, rates of depression levels (PHQ-9 questionnaire) and sociodemographic information (age, gender, social status, level of education) were obtained. …”

Presentation_1_The impact of challenge and hindrance stressors on knowledge hiding: the mediating role of job crafting and work withdrawal.pdf by Le Wang (165105)

“…Specifically, challenge stressors increase the likelihood of knowledge hiding through work withdrawal while simultaneously decreasing it through job crafting; notably, the former pathway has a greater effect. …”

Table_1_Refugees’ integration and emotional distress over the course of 9 months.pdf by Flurina Potter (16537140)

Table_1_Refugees’ integration and emotional distress over the course of 9 months.pdf by Flurina Potter (16537140)

Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

Stability differences between condition 1 and other conditions across participants on the hemiparetic (HP) side. by Hyung Suk Yang (20442438)

The incidence of grooming is most influenced by the addition of an opaque divider, as compared to manipulanda. by Matthew D. Boulanger (22600966)

Table_1_Introducing Open Dialogue as part of the WHO QualityRights Project in South Korea: experiences and opinions from an introductory workshop and 1-year pilot practice.DOCX by Sooni Cho (19863429)

The impact of MDA on hookworm prevalence and intensity of infection stratified by treatment with IDA or DA. by Jannet A. Tobon Ramos (20855642)

Receiver operating characteristic curve for anti-NIE antibodies for <i>S. stercoralis.</i> by Jannet A. Tobon Ramos (20855642)

Ranking position of feature importance for each cluster in the post-vaccination period. by Jéssica Villar (21453137)

Ranking position of feature importance for each cluster in the pre-vaccination period. by Jéssica Villar (21453137)

SHAP Values per cluster in the pre-vaccination period show each feature’s importance on COVID-19 mortality. by Jéssica Villar (21453137)

SHAP Values per cluster in the post-vaccination period show each feature’s importance on COVID-19 mortality. by Jéssica Villar (21453137)

Data Sheet 1_Disproportionate impact of the COVID-19 pandemic on socially vulnerable communities: the case of Jane and Finch in Toronto, Ontario.docx by Zahra Movahedi Nia (9238798)

“…The number of patients during the COVID-19 pandemic versus before that decreased significantly more for pop-smear tests (p = 0.041) and surgery waitlists (p = 0.037) for the Jane and Finch community.…”

Summary of study eligibility criteria. by Biban Gill (1473337)

“…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”

Summary of study participation and feasibility. by Biban Gill (1473337)

“…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”

Analysis of host and interferon-induced responses in glucose/galactose infected with vaccinia virus. by Tyron Chang (9922533)

qPCR of vaccinia virus RNAs <i>IRF1</i> KO cells: glucose with and without IFN-γ priming. by Tyron Chang (9922533)